BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25735126)

  • 21. Review article: medical treatment of severe ulcerative colitis.
    Rizzello F; Gionchetti P; Venturi A; Campieri M
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():7-10. PubMed ID: 12786606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
    Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Nachury M; Moreau J; Delchier JC; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Dupas JL; Carbonnel F; Bommelaer G; Coffin B; Roblin X; Van Assche G; Esteve M; Färkkilä M; Gisbert JP; Marteau P; Nahon S; de Vos M; Franchimont D; Mary JY; Colombel JF; Lémann M;
    Lancet; 2012 Dec; 380(9857):1909-15. PubMed ID: 23063316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of acute severe ulcerative colitis.
    Van Assche G; Vermeire S; Rutgeerts P
    Gut; 2011 Jan; 60(1):130-3. PubMed ID: 21030524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates.
    Moore AC; Bressler B
    Dig Dis Sci; 2020 Feb; 65(2):576-580. PubMed ID: 31093812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.
    Rolny P; Vatn M
    Scand J Gastroenterol; 2013 Feb; 48(2):131-5. PubMed ID: 23110487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
    Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID;
    Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of severe or corticosteroid resistant ulcerative colitis].
    Carbonnel F
    Gastroenterol Clin Biol; 2007 Apr; 31(4):398-403. PubMed ID: 17483777
    [No Abstract]   [Full Text] [Related]  

  • 28. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus.
    Tsukamoto H; Tanida S; Mizoshita T; Ozeki K; Ebi M; Shimura T; Mori Y; Kataoka H; Kamiya T; Joh T
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):714-8. PubMed ID: 23411870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of acute severe ulcerative colitis.
    Doherty GA; Cheifetz AS
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fulminant colitis.
    Sands BE
    J Gastrointest Surg; 2008 Dec; 12(12):2157-9. PubMed ID: 18766416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the importance of infliximab and cyclosporine in the treatment of corticosteroid-refractory severe ulcerative colitis?
    Bengi G; Akpinar H
    Turk J Gastroenterol; 2012; 23 Suppl 2():7-12. PubMed ID: 23576083
    [No Abstract]   [Full Text] [Related]  

  • 32. Infliximab salvage therapy after cyclosporine in an acute flare of chronic ulcerative colitis.
    Lam EC; Bailey RJ
    Can J Gastroenterol; 2003 Mar; 17(3):198-200. PubMed ID: 12677271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
    Croft A; Walsh A; Doecke J; Cooley R; Howlett M; Radford-Smith G
    Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of medical rescue therapy in the management of acute severe ulcerative colitis: the surgical perspective.
    Koltun WA
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):325-7. PubMed ID: 19673618
    [No Abstract]   [Full Text] [Related]  

  • 35. Current treatment of ulcerative colitis.
    Meier J; Sturm A
    World J Gastroenterol; 2011 Jul; 17(27):3204-12. PubMed ID: 21912469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical therapy of inflammatory bowel diseases: ulcerative colitis].
    Lakatos L; Lakatos PL
    Orv Hetil; 2007 Jun; 148(25):1163-70. PubMed ID: 17573252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute severe colitis: infliximab and/or cyclosporine?
    Fabro M; Szabo H; Terrosu G; Avellini C; Tabuso M; Fiorino G; Sorrentino D
    Curr Drug Targets; 2011 Sep; 12(10):1448-53. PubMed ID: 21466485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infliximab for the treatment of acute exacerbations of ulcerative colitis.
    Bryan S; Andronis L; Hyde C; Connock M; Fry-Smith A; Wang D
    Health Technol Assess; 2010 May; 14 Suppl 1():9-15. PubMed ID: 20507798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current status of treatment of inflammatory bowel disease].
    Rodríguez-Moranta F; Soriano-Izquierdo A; Guardiola J
    Cir Esp; 2007 Nov; 82(5):254-9. PubMed ID: 18021623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute severe ulcerative colitis: from pathophysiology to clinical management.
    Hindryckx P; Jairath V; D'Haens G
    Nat Rev Gastroenterol Hepatol; 2016 Nov; 13(11):654-664. PubMed ID: 27580687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.